Viewing Study NCT00947895


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-04-12 @ 1:02 PM
Study NCT ID: NCT00947895
Status: TERMINATED
Last Update Posted: 2016-03-22
First Post: 2009-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone
Sponsor: Neurologique Foundation, Inc.
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Q1001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View